Skip to main content
HR 326 116th Congress House International Affairs Asia Birth defects Child health Conflicts and wars Congressional oversight Disability and paralysis Employment and training programs Environmental health Foreign aid and international relief Government lending and loan guarantees Hazardous wastes and toxic substances Health care coverage and access Health information and medical records Health programs administration and funding Health technology, devices, supplies Home and outpatient care Medical education Medical research Medical tests and diagnostic methods

Victims of Agent Orange Relief Act of 2019

Introduced: January 8, 2019 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 1, 2019
Referred to the Subcommittee on Health.
Jan 25, 2019
Referred to the Subcommittee on Health.
Jan 8, 2019
Referred to the Committee on Veterans' Affairs, and in addition to the Committees on Energy and Commerce, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 8, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Victims of Agent Orange Relief Act of 2019

This bill requires the Department of State, the Department of Health and Human Services (HHS), and the Department of Veterans Affairs (VA) to provide assistance to people in Vietnam in relation to Agent Orange exposure.

Specifically, the State Department must provide assistance (1) to address the health care needs of certain residents of Vietnam affected by Agent Orange exposure, (2) to institutions in Vietnam that provide health care to such individuals, (3) to improve housing and reduce poverty for specified individuals and their families, and (4) to remediate areas of Vietnam that contain high levels of Agent Orange.

HHS must (1) make grants to public health organizations and Vietnamese-American organizations to conduct a broad health assessment of Vietnamese-Americans who may have been exposed to Agent Orange and their descendants; and (2) establish centers in U.S. locations where large populations of Vietnamese-Americans reside to provide assessment, counseling, and treatment for conditions related to Agent Orange exposure.

Under the bill, certain benefits will be made available to the children of male veterans who served in Vietnam who are affected by certain birth defects. Currently, these benefits are only available to the children of women Vietnam veterans. The VA shall require any health care provider with whom the VA enters into a contract for the provision of health care to such children to provide the VA access to their medical records for research into the intergenerational effects of Agent Orange exposure.

What's happening now February 1, 2019

Referred to the Subcommittee on Health.

 Committees of jurisdiction 5